[HTML] nih.gov

[HTML][HTML] Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation

M Bianchi, N Orlando, O Barbagallo… - Blood …, 2021 - ncbi.nlm.nih.gov
Background For neonates and preterm infants, in whom a transfusion dose is low, the use of
red blood cells (RBC) from cord blood appears to be feasible. Standardisation of …
被引用次数：9 相关文章

Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation

M Bianchi, N Orlando, B Ombretta… - BLOOD …, 2020 - publicatt.unicatt.it
Background: For neonates and preterm infants, in whom a transfusion dose is low, the use of
red blood cells (RBC) from cord blood appears to be feasible. Standardisation of …

Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation.

M Bianchi, N Orlando, O Barbagallo… - Blood Transfusion …, 2020 - europepmc.org
Background For neonates and preterm infants, in whom a transfusion dose is low, the use of
red blood cells (RBC) from cord blood appears to be feasible. Standardisation of …

Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation

M Bianchi, N Orlando, O Barbagallo… - Blood transfusion …, 2021 - pubmed.ncbi.nlm.nih.gov
Background For neonates and preterm infants, in whom a transfusion dose is low, the use of
red blood cells (RBC) from cord blood appears to be feasible. Standardisation of …

Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation

M Bianchi, N Orlando, O Barbagallo… - Blood …, 2021 - bloodtransfusion.it
Background-For neonates and preterm infants, in whom a transfusion dose is low, the use of
red blood cells (RBC) from cord blood appears to be feasible. Standardisation of …